NCT05657340|Completed
Loading search results
Sponsor study identifier
interventional
86
1 country
1
Study Start
January 1, 2019
Actual (reported)Primary Completion
May 1, 2020
Actual (reported)Study Completion
May 1, 2020
Actual (reported)This a case control study on seasickness susceptibility. 86 healthy maritime personal were divided to seasickness susceptible and non susceptible groups based on a seasickness questionnaire (Golding) and motion sickness score. All subjects from both groups underwent video head impulse testing (vHIT). VHIT parameters - gain, asymmetry ect were compared between both groups.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 1, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2019
Actual (reported)May 1, 2020
Actual (reported)May 1, 2020
Actual (reported)December 11, 2022
Actual (reported)December 20, 2022
Actual (reported)vHIT gain
measurement of semicircular canal function
Immediate
paired semi-circular canal asymmetry
(\|1st canal gain-2nd canal gain\|)/(1st canal gain+2nd canal gain)
Immediate
anterior semicircular canal gain o ipsilateral horizontal canal gain
Immediate
43 seasickness susceptible maritime crewmembers underwent video-head impulse test
43 seasickness non-susceptible maritime crewmembers underwent video-head impulse test
Video-head impulse testing is a recent diagnostic bed-side test for evaluation of semi-circular canal function.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Israeli Naval Medical Institute
Haifa, 2705335, Israel
Gutkovich YE, Jamison A, Lagami D, Fonar Y, Siag K, Tal D. Video head impulse test and seasickness susceptibility. Exp Brain Res. 2025 Apr 16;243(5):119. doi: 10.1007/s00221-025-07078-9.
86 participants (actual enrollment reported by the registry).
First Submitted
December 11, 2022
First Posted
December 20, 2022
Study Start
January 1, 2019
Actual (reported)Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
Contact the study team to confirm eligibility.
Primary Completion
May 1, 2020
Actual (reported)Study Completion
May 1, 2020
Actual (reported)Last Updated
December 20, 2022
Record last verified: 2022-12
Information will be available upon reasonable request from corresponding author
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: